<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38629901</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>20</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1550-6606</ISSN><JournalIssue CitedMedium="Internet"><Volume>212</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of immunology (Baltimore, Md. : 1950)</Title><ISOAbbreviation>J Immunol</ISOAbbreviation></Journal><ArticleTitle>Enterovirus 71 Activates Plasmacytoid Dendritic Cell-Dependent PSGL-1 Binding Independent of Productive Infection.</ArticleTitle><Pagination><StartPage>1782</StartPage><EndPage>1790</EndPage><MedlinePgn>1782-1790</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4049/jimmunol.2300407</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) is a significant causative agent of hand, foot, and mouth disease, with potential serious neurologic complications or fatal outcomes. The lack of effective treatments for EV71 infection is attributed to its elusive pathogenicity. Our study reveals that human plasmacytoid dendritic cells (pDCs), the main type I IFN-producing cells, selectively express scavenger receptor class B, member 2 (SCARB2) and P-selectin glycoprotein ligand 1 (PSGL-1), crucial cellular receptors for EV71. Some strains of EV71 can replicate within pDCs and stimulate IFN-α production. The activation of pDCs by EV71 is hindered by Abs to PSGL-1 and soluble PSGL-1, whereas Abs to SCARB2 and soluble SCARB2 have a less pronounced effect. Our data suggest that only strains binding to PSGL-1, more commonly found in severe cases, can replicate in pDCs and induce IFN-α secretion, highlighting the importance of PSGL-1 in these processes. Furthermore, IFN-α secretion by pDCs can be triggered by EV71 or UV-inactivated EV71 virions, indicating that productive infection is not necessary for pDC activation. These findings provide new insights into the interaction between EV71 and pDCs, suggesting that pDC activation could potentially mitigate the severity of EV71-related diseases.</AbstractText><CopyrightInformation>Copyright © 2024 by The American Association of Immunologists, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xuyuan</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-6305-1556</Identifier><AffiliationInfo><Affiliation>National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Zhao</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0003-2916-5979</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Strategic Support Force Characteristic Medical Center, The Chinese People's Liberation Army, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jialong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jingyun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nie</LastName><ForeName>Xiaohua</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shouli</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Strategic Support Force Characteristic Medical Center, The Chinese People's Liberation Army, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Liguo</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-9795-0314</Identifier><AffiliationInfo><Affiliation>National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Chinese Academy of Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>82001681</GrantID><Agency>MOST | National Natural Science Foundation of China (NSFC)</Agency><Country /></Grant><Grant><GrantID>82371853</GrantID><Agency>MOST | National Natural Science Foundation of China (NSFC)</Agency><Country /></Grant><Grant><GrantID>81921005</GrantID><Agency>MOST | National Natural Science Foundation of China (NSFC)</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Immunol</MedlineTA><NlmUniqueID>2985117R</NlmUniqueID><ISSNLinking>0022-1767</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C084882">P-selectin ligand protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C074299">SCARB2 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003713" MajorTopicYN="Y">Dendritic Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008562" MajorTopicYN="Y">Membrane Glycoproteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051907" MajorTopicYN="Y">Lysosomal Membrane Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016898" MajorTopicYN="Y">Interferon-alpha</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051116" MajorTopicYN="N">Receptors, Scavenger</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no financial conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>20</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>17</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>17</Day><Hour>9</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38629901</ArticleId><ArticleId IdType="pmc">PMC11102030</ArticleId><ArticleId IdType="doi">10.4049/jimmunol.2300407</ArticleId><ArticleId IdType="pii">266827</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ooi, M. H., Wong S. C., Lewthwaite P., Cardosa M. J., Solomon T.. 2010. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 9: 1097–1105.</Citation><ArticleIdList><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, S. W., Cheng D., Wang J. R.. 2019. Enterovirus A71: virulence, antigenicity, and genetic evolution over the years. J. Biomed. Sci. 26: 81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6802317</ArticleId><ArticleId IdType="pubmed">31630680</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, C. C., Liu C. C., Chang Y. C., Chen C. Y., Wang S. T., Yeh T. F.. 1999. Neurologic complications in children with enterovirus 71 infection. N. Engl. J. Med. 341: 936–942.</Citation><ArticleIdList><ArticleId IdType="pubmed">10498488</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi, S., Yamashita Y., Li J., Hanagata N., Minowa T., Takemura T., Koike S.. 2009. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat. Med. 15: 798–801.</Citation><ArticleIdList><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, D., Zhao Y., Kotecha A., Fry E. E., Kelly J. T., Wang X., Rao Z., Rowlands D. J., Ren J., Stuart D. I.. 2019. Unexpected mode of engagement between enterovirus 71 and its receptor SCARB2. Nat. Microbiol. 4: 414–419.</Citation><ArticleIdList><ArticleId IdType="pubmed">30531980</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura, Y., Shimojima M., Tano Y., Miyamura T., Wakita T., Shimizu H.. 2009. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat. Med. 15: 794–797.</Citation><ArticleIdList><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan, C. W., Poh C. L., Sam I. C., Chan Y. F.. 2013. Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. J. Virol. 87: 611–620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3536405</ArticleId><ArticleId IdType="pubmed">23097443</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi, K., Koike S.. 2020. Cellular receptors for enterovirus A71. J. Biomed. Sci. 27: 23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6954530</ArticleId><ArticleId IdType="pubmed">31924205</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin, H. Y., Yang Y. T., Yu S. L., Hsiao K. N., Liu C. C., Sia C., Chow Y. H.. 2013. Caveolar endocytosis is required for human PSGL-1-mediated enterovirus 71 infection. J. Virol. 87: 9064–9076.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3754029</ArticleId><ArticleId IdType="pubmed">23760234</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura, Y., Lee H., Hafenstein S., Kataoka C., Wakita T., Bergelson J. M., Shimizu H.. 2013. Enterovirus 71 binding to PSGL-1 on leukocytes: VP1-145 acts as a molecular switch to control receptor interaction. PLoS Pathog. 9: e1003511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3723564</ArticleId><ArticleId IdType="pubmed">23935488</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan, C. W., Sam I. C., Lee V. S., Wong H. V., Chan Y. F.. 2017. VP1 residues around the five-fold axis of enterovirus A71 mediate heparan sulfate interaction. Virology 501: 79–87.</Citation><ArticleIdList><ArticleId IdType="pubmed">27875780</ArticleId></ArticleIdList></Reference><Reference><Citation>Kataoka, C., Suzuki T., Kotani O., Iwata-Yoshikawa N., Nagata N., Ami Y., Wakita T., Nishimura Y., Shimizu H.. 2015. The role of VP1 amino acid residue 145 of enterovirus 71 in viral fitness and pathogenesis in a cynomolgus monkey model. PLoS Pathog. 11: e1005033.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4504482</ArticleId><ArticleId IdType="pubmed">26181772</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi, S., Fujii K., Koike S.. 2014. Receptors for enterovirus 71. Emerg. Microbes Infect. 3: e53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4126179</ArticleId><ArticleId IdType="pubmed">26038749</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang, S. C., Li W. C., Chen G. W., Tsao K. C., Huang C. G., Huang Y. C., Chiu C. H., Kuo C. Y., Tsai K. N., Shih S. R., Lin T. Y.. 2012. Genetic characterization of enterovirus 71 isolated from patients with severe disease by comparative analysis of complete genomes. J. Med. Virol. 84: 931–939.</Citation><ArticleIdList><ArticleId IdType="pubmed">22499017</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, R., Zou Q., Chen L., Zhang H., Wang Y.. 2011. Molecular analysis of virulent determinants of enterovirus 71. PLoS One. 6: e26237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3198388</ArticleId><ArticleId IdType="pubmed">22039449</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, Y., Fu C., Wu S., Chen X., Shi Y., Zhou B., Zhang L., Zhang F., Wang Z., Zhang Y., et al. . 2014. A novel finding for enterovirus virulence from the capsid protein VP1 of EV71 circulating in mainland China. Virus Genes. 48: 260–272.</Citation><ArticleIdList><ArticleId IdType="pubmed">24442718</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, B., Wu X., Huang K., Li L., Zheng L., Wan C., He M. L., Zhao W.. 2014. The variations of VP1 protein might be associated with nervous system symptoms caused by enterovirus 71 infection. BMC Infect. Dis. 14: 243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4101859</ArticleId><ArticleId IdType="pubmed">24886383</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi, K., Mizuta K., Koike S.. 2020. Heparan sulfate attachment receptor is a major selection factor for attenuated enterovirus 71 mutants during cell culture adaptation. PLoS Pathog. 16: e1008428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7105141</ArticleId><ArticleId IdType="pubmed">32187235</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi, K., Sudaka Y., Takashino A., Imura A., Fujii K., Koike S.. 2018. Amino acid variation at VP1-145 of enterovirus 71 determines attachment receptor usage and neurovirulence in human scavenger receptor B2 transgenic mice. J. Virol. 92: e00681-18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6052303</ArticleId><ArticleId IdType="pubmed">29848584</ArticleId></ArticleIdList></Reference><Reference><Citation>Tee, H. K., Tan C. W., Yogarajah T., Lee M. H. P., Chai H. J., Hanapi N. A., Yusof S. R., Ong K. C., Lee V. S., Sam I. C., Chan Y. F.. 2019. Electrostatic interactions at the five-fold axis alter heparin-binding phenotype and drive enterovirus A71 virulence in mice. PLoS Pathog. 15: e1007863.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6881073</ArticleId><ArticleId IdType="pubmed">31730673</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii, K., Sudaka Y., Takashino A., Kobayashi K., Kataoka C., Suzuki T., Iwata-Yoshikawa N., Kotani O., Ami Y., Shimizu H., et al. . 2018. VP1 amino acid residue 145 of enterovirus 71 is a key residue for its receptor attachment and resistance to neutralizing antibody during cynomolgus monkey infection. J. Virol. 92: e00682-18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6052295</ArticleId><ArticleId IdType="pubmed">29848582</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, Y. J. 2005. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23: 275–306.</Citation><ArticleIdList><ArticleId IdType="pubmed">15771572</ArticleId></ArticleIdList></Reference><Reference><Citation>Barchet, W., Cella M., Colonna M.. 2005. Plasmacytoid dendritic cells–virus experts of innate immunity. Semin. Immunol. 17: 253–261.</Citation><ArticleIdList><ArticleId IdType="pubmed">15990333</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei, X., Liu X., Ma Y., Sun Z., Yang Y., Jin Q., He B., Wang J.. 2010. The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J. Virol. 84: 8051–8061.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2916543</ArticleId><ArticleId IdType="pubmed">20519382</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei, X., Sun Z., Liu X., Jin Q., He B., Wang J.. 2011. Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. J. Virol. 85: 8811–8818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3165803</ArticleId><ArticleId IdType="pubmed">21697485</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei, X., Xiao X., Xue Q., Jin Q., He B., Wang J.. 2013. Cleavage of interferon regulatory factor 7 by enterovirus 71 3C suppresses cellular responses. J. Virol. 87: 1690–1698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3554134</ArticleId><ArticleId IdType="pubmed">23175366</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu, J., Yi L., Zhao J., Yu J., Chen Y., Lin M. C., Kung H. F., He M. L.. 2012. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J. Virol. 86: 3767–3776.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3302529</ArticleId><ArticleId IdType="pubmed">22258259</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Z., Wu Y., Li H., Li W., Tan J., Qiao W.. 2021. 3C protease of enterovirus 71 cleaves promyelocytic leukemia protein and impairs PML-NBs production. Virol. J. 18: 255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8686290</ArticleId><ArticleId IdType="pubmed">34930370</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, Y., Zhang Z., Zhao X., Yu R., Zhang X., Wu S., Liu J., Chi X., Song X., Fu L., et al. . 2014. Enterovirus 71 inhibits cellular type I interferon signaling by downregulating JAK1 protein expression. Viral Immunol. 27: 267–276.</Citation><ArticleIdList><ArticleId IdType="pubmed">24905060</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo, H., Zhang J., Zhang X., Wang Y., Yu H., Yin X., Li J., Du P., Plumas J., Chaperot L., et al. . 2015. SCARB2/LIMP-2 regulates IFN production of plasmacytoid dendritic cells by mediating endosomal translocation of TLR9 and nuclear translocation of IRF7. J. Immunol. 194: 4737–4749.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4506778</ArticleId><ArticleId IdType="pubmed">25862818</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong, M., Zhu H., Zhou J., Yang C., Feng J., Huang X., Ji G., Xu H., Zhu P.. 2014. Cryo-electron microscopy study of insect cell-expressed enterovirus 71 and coxsackievirus a16 virus-like particles provides a structural basis for vaccine development. J. Virol. 88: 6444–6452.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4093858</ArticleId><ArticleId IdType="pubmed">24672036</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, X., Peng W., Ren J., Hu Z., Xu J., Lou Z., Li X., Yin W., Shen X., Porta C., et al. . 2012. A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nat. Struct. Mol. Biol. 19: 424–429.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3378640</ArticleId><ArticleId IdType="pubmed">22388738</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, X., Yang P., Wang N., Zhang J., Li J., Guo H., Yin X., Rao Z., Wang X., Zhang L.. 2017. The binding of a monoclonal antibody to the apical region of SCARB2 blocks EV71 infection. Protein Cell 8: 590–600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5546930</ArticleId><ArticleId IdType="pubmed">28447294</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijhuis, M., van Maarseveen N., Schuurman R., Verkuijlen S., de Vos M., Hendriksen K., van Loon A. M.. 2002. Rapid and sensitive routine detection of all members of the genus enterovirus in different clinical specimens by real-time PCR. J. Clin. Microbiol. 40: 3666–3670.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC130891</ArticleId><ArticleId IdType="pubmed">12354863</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore, K. L., Patel K. D., Bruehl R. E., Li F., Johnson D. A., Lichenstein H. S., Cummings R. D., Bainton D. F., McEver R. P.. 1995. P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J. Cell Biol. 128: 661–671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2199883</ArticleId><ArticleId IdType="pubmed">7532174</ArticleId></ArticleIdList></Reference><Reference><Citation>Laszik, Z., Jansen P. J., Cummings R. D., Tedder T. F., McEver R. P., Moore K. L.. 1996. P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoietic cells. Blood 88: 3010–3021.</Citation><ArticleIdList><ArticleId IdType="pubmed">8874199</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilliet, M., Cao W., Liu Y. J.. 2008. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 8: 594–606.</Citation><ArticleIdList><ArticleId IdType="pubmed">18641647</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi, S., Ohka S., Fujii K., Koike S.. 2013. Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71. J. Virol. 87: 3335–3347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3592140</ArticleId><ArticleId IdType="pubmed">23302872</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordey, S., Petty T. J., Schibler M., Martinez Y., Gerlach D., van Belle S., Turin L., Zdobnov E., Kaiser L., Tapparel C.. 2012. Identification of site-specific adaptations conferring increased neural cell tropism during human enterovirus 71 infection. PLoS Pathog. 8: e1002826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3406088</ArticleId><ArticleId IdType="pubmed">22910880</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseligka, E. D., Sobo K., Stoppini L., Cagno V., Abdul F., Piuz I., Meylan P., Huang S., Constant S., Tapparel C.. 2018. A VP1 mutation acquired during an enterovirus 71 disseminated infection confers heparan sulfate binding ability and modulates ex vivo tropism. PLoS Pathog. 14: e1007190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6093697</ArticleId><ArticleId IdType="pubmed">30075025</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, L., Yin H., An Z., Feng Z.. 2015. Considerations for developing an immunization strategy with enterovirus 71 vaccine. Vaccine 33: 1107–1112.</Citation><ArticleIdList><ArticleId IdType="pubmed">25444807</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>